Gretchen Shull, PA
Physician Assistant · Mentor, OHNPI 1699290783
Payments from drug & device makers
Across 189 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$593
- Johnson & Johnson$570
- Regeneron Healthcare Solutions, Inc.$401
- Lilly USA, LLC$201
- Sanofi$189
- Pfizer$121
- plus $975 from 17 others
What the payments were for
- Food & beverage$2,87894%
- Education$1716%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $593 |
| Johnson & Johnson | 65 | $570 |
| Regeneron Healthcare Solutions, Inc. | 14 | $401 |
| Lilly USA, LLC | 9 | $201 |
| Sanofi | 8 | $189 |
| Pfizer | 8 | $121 |
| Galderma Laboratories, L.p. | 7 | $118 |
| UCB, Inc. | 5 | $110 |
| Incyte Corporation | 5 | $98 |
| Amgen | 5 | $91 |
| Sun Pharmaceutical Industries Inc. | 4 | $90 |
| LEO Pharma Inc. | 4 | $84 |
| Dermavant Sciences, Inc. | 4 | $81 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $72 |
| Novartis | 3 | $57 |
| Boehringer Ingelheim | 2 | $34 |
| VYNE Pharmaceuticals Inc. | 1 | $25 |
| Nobelpharma America, LLC | 1 | $24 |
| Almirall LLC | 1 | $22 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $20 |
| Biofrontera Inc. | 1 | $19 |
| Strata Skin Sciences, Inc. | 1 | $15 |
| LNHC, Inc | 1 | $15 |
How this compares
$3,050 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $60,493 |
| Clobetasol Propionate | 76 | $3,569 |
| Fluorouracil | 29 | $1,874 |
| ValacyclovirValacyclovir Hcl | 14 | $1,463 |
| Clindamycin Phosphate | 21 | $727 |
| Doxycycline Hyclate | 33 | $649 |
| Triamcinolone Acetonide | 63 | $367 |
| Fluocinonide | 11 | $281 |
| Ketoconazole | 18 | $192 |
| Mupirocin | 25 | $141 |
| Hydrocortisone | 21 | $79 |
| Finasteride | 18 | $62 |
| Prednisone | 18 | $50 |
| Nystatin | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Mentor
- Rachel McKernanMentor$13K
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alan OdonnellCincinnati$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.